Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a significant decline in short interest in October. As of October 15th, there was short interest totalling 299,300 shares, a decline of 45.1% from the September 30th total of 544,800 shares. Based on an average trading volume of 1,700,000 shares, the days-to-cover ratio is presently 0.2 days.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of Aethlon Medical in a research note on Wednesday. They set a “sell” rating on the stock.

Aethlon Medical Stock Up 1.4 %

Shares of Aethlon Medical stock opened at $0.38 on Friday. The business has a 50-day moving average price of $0.41 and a 200 day moving average price of $0.59. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.35. The firm has a market cap of $5.21 million, a P/E ratio of -0.08 and a beta of 1.74.

Aethlon Medical (NASDAQ:AEMD) last issued its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.10. During the same period in the prior year, the company earned ($1.30) earnings per share. As a group, equities research analysts anticipate that Aethlon Medical will post -1.1 earnings per share for the current year.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.